Home » Health » New Diabetes Treatment Offers Hope for Northeast Ohio Patients

New Diabetes Treatment Offers Hope for Northeast Ohio Patients

by Dr. Michael Lee – Health Editor

New Single-Injection Diabetes Treatment to Launch in Cleveland Next Month

CLEVELAND, ‌OH – A‌ potentially life-saving treatment for‍ severe Type 1 diabetes will become available to patients in Northeast Ohio next month, offered exclusively at University Hospitals (UH). The innovative therapy involves a single injection of cells from a deceased donorS‌ pancreas,aiming to restore the body’s ability to regulate⁤ insulin levels.

For patients ‍battling diabetic ketoacidosis – a risky complication where individuals lose the ability to detect critical blood sugar fluctuations – ⁢this ​treatment offers ​a new hope. “I have ⁣had patients who never woke up ‌from their sleep,” said Betul Hatipoglu, medical director of the Diabetes &‍ Metabolic ⁤Care Center ‍at UH. “I had patients who had car accidents from⁤ hypoglycemia, never recovered fully⁣ from brain damage that they ⁣had.” The therapy is ‍designed​ for extreme cases, functioning as a last resort for those‍ facing the most severe⁢ consequences of the disease.

Diabetic ketoacidosis can ‍rapidly lead⁢ to seizures, unconsciousness, coma, and even death.⁤ The treatment, approved by the Food and Drug Administration in 2023 and⁣ currently available at ‍four other ‌sites nationwide, works⁣ by essentially replacing the function of a failing pancreas. Hatipoglu ⁢likened⁣ the approach ⁤to treating cancer or congestive heart ‌failure, stating, “You are looking at ⁤this disease like it’s… ⁤an end stage diabetes.”

However, the treatment isn’t without risks. Patients ⁢will be carefully screened to‍ ensure they are cancer-free and have good kidney function, as the therapy can increase susceptibility to infections,​ raise the risk‌ of skin cancer, and potentially damage kidney ‍function.

UH will begin accepting applications for⁤ the treatment​ through its hospital website within a month. Most health insurance plans are expected to cover ‌the procedure due⁤ to its FDA⁣ approval. This new offering marks a critically importent advancement in diabetes care for the region, providing a⁢ critical⁣ option for patients facing life-threatening complications.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.